SGLT2 Inhibitor Use Not Tied to Increased Fracture Risk in CKD - HealthDay News
6/1/2022 12:00:00 AM2 years 11 months ago
by Physician’s Briefing Staff
by Physician’s Briefing Staff
Compared with DPP-4 inhibitor use, SGLT2 inhibitor use not associated with higher risk for fractures, regardless of eGFR
WEDNESDAY, June 1, 2022 (HealthDay News) -- For older adults, initiation of a sodium-glucose cotransporter-2 (SGLT2) inhibitor is not associated with higher fracture risk compared with initiation of … [+1511 chars]
full article...